WCN25-708 OUTCOMES IN NEWLY DIAGNOSED MULTIPLE MYELOMA WITH RENAL INVOLVEMENT: RETROSPECTIVE STUDY FROM TERTIARY CARE CENTRE IN NORTHERN INDIA

Of all newly diagnosed multiple myeloma patients, 20-40% have renal impairment as defined byIMWG 2016criteria. Newly diagnosed multiple myeloma (NDMM) patients with renal involvement(RI) have been reported to have significantly inferior survival compared to those without renal involvement. In the post- bortezomib era, although outcome of such patients has improved in Western countries, data from resource poor LMIC countries is sparse. Younger age at diagnosis, advanced disease at presentation, higher risk of infections, limited finances and supportive care could potentially attribute to inferior outcomes in MM with renal impairment.

Authors

Institutions

Publication Details

Journal
Kidney International Reports
Published
2025-01-27
DOI
https://doi.org/10.1016/j.ekir.2024.11.1205
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

WCN25-708 OUTCOMES IN NEWLY DIAGNOSED MULTIPLE MYELOMA WITH RENAL INVOLVEMENT: RETROSPECTIVE STUDY FROM TERTIARY CARE CENTRE IN NORTHERN INDIA

Manas Ranjan Patel, Anupma Kaul, Sanjeev Yadav, Mugdha Sathe et al.
2 links
Kidney International Reports
Multiple Myeloma Research and Treatments
article

WCN25-708 OUTCOMES IN NEWLY DIAGNOSED MULTIPLE MYELOMA WITH RENAL INVOLVEMENT: RETROSPECTIVE STUDY FROM TERTIARY CARE CENTRE IN NORTHERN INDIA

Manas Ranjan Patel, Anupma Kaul, Sanjeev Yadav, Mugdha Sathe, Deep Gala, Narayan Prasad
article en

Abstract

Of all newly diagnosed multiple myeloma patients, 20-40% have renal impairment as defined byIMWG 2016criteria. Newly diagnosed multiple myeloma (NDMM) patients with renal involvement(RI) have been reported to have significantly inferior survival compared to those without renal involvement. In the post- bortezomib era, although outcome of such patients has improved in Western countries, data from resource poor LMIC countries is sparse. Younger age at diagnosis, advanced disease at presentation, higher risk of infections, limited finances and supportive care could potentially attribute to inferior outcomes in MM with renal impairment.

Kidney International ReportsVol. 10(2)
Centre of Biomedical Research (IN)
Good health and well-being
Openalex Percentile: Top 98%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.